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Background: The purpose was to assess in Italy the clinical
features at diagnosis of inflammatory bowel disease (IBD) in chil-
dren.
Methods: In 1996 an IBD register of disease onset was established
on a national scale.
Results: Up to the end of 2003, 1576 cases of pediatric IBD were
recorded: 810 (52%) ulcerative colitis (UC), 635 (40%) Crohn’s
disease (CD), and 131 (8%) indeterminate colitis (IC). In the period
1996–2003 an increase of IBD incidence from 0.89 to 1.39/105
inhabitants aged 18 years was observed. IBD was more frequent
among children aged between 6 and 12 years (57%) but 20% of
patients had onset of the disease under 6 years of age; 28 patients
were 1 year of age. Overall, 11% had 1 or more family members
with IBD. The mean interval between onset of symptoms and
diagnosis was higher in CD (10.1 months) and IC (9 months) versus
UC (5.8 months). Extended colitis was the most frequent form in UC
and ileocolic involvement the most frequent in CD. Upper intestinal
tract involvement was present in 11% of CD patients. IC locations
were similar to those of UC. Bloody diarrhea and abdominal pain
were the most frequent symptoms in UC and IC, and abdominal pain
and diarrhea in CD. Extraintestinal symptoms were more frequent in
CD than in UC.
Conclusions: The IBD incidence in children and adolescents in
Italy shows an increasing trend for all 3 pathologies. UC diagnoses
exceeded CD.
(Inflamm Bowel Dis 2008;14:1246–1252)
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Inflammatory bowel diseases (IBD) include ulcerative coli-tis (UC), Crohn’s disease (CD), and indeterminate colitis
(IC). It is estimated that 20%–30% of patients experience
onset of their symptoms under 20 years of age.1-4 There are
literature reports of cases where the diseases began before 1
year of age.5,6 The pathogenesis of IBD is still unknown;
environmental, genetic, and immunological factors seem to
play an important role.7–11
Since the 1950s the available epidemiological data on
the adult population showed an increased incidence of both
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UC and CD and, especially in North America and in Europe,
a prevalence of CD. European data show that northern coun-
tries present higher rates of IBD than southern ones.12–15
The incidence of pediatric IBD varies in different coun-
tries, the highest being reported in Western countries, espe-
cially in the northern parts of America and Europe.16–20 Most
studies report a predominance of CD incidence over UC,
although some articles indicate the contrary.7,16,21 However,
according to recent reports the incidence of CD is rapidly
increasing, especially in young children, while the UC inci-
dence remains stable.17,18
Due to the lack of studies on pediatric patients affected
by IBD in Italy, the Italian Society of Pediatric Gastroenter-
ology, Hepatology and Nutrition (SIGENP) established a
National Register of Pediatric IBD in order to define demo-
graphics, disease distribution at diagnosis, clinical presenta-
tion, and family history in Italian children and adolescents.
MATERIALS AND METHODS
Study Setting
In 1996 the SIGENP IBD Study Group started an IBD reg-
ister of pediatric and juvenile onset on a national scale. It was
established to input data at the time of diagnosis of IBD
patients whose symptoms began before 18 years of age. A
summary file of data from every patient at the time of diag-
nosis was developed. Data collected included: gender, age at
onset of symptoms, age at diagnosis, type of disease (CD,
UC, IC), symptoms, locations, and family history for IBD.
One center was chosen for collecting data and coordinating
the study.
All 40 centers of pediatric gastroenterology present in
Italy distributed all over the national territory participated.
The first phase of the register was retrospective and the
participating centers were invited to collect data of patients
diagnosed before 1996 from their medical records. A second
prospective phase consisted of the compilation of a file for
each new diagnosis. All centers could fill out the forms
online. Data were protected by a username and a password
different for each participant so that each had the possibility
to access, modify, and insert data concerning their own pa-
tients. Initials, date, and place of birth of each patient helped
to avoid registration of the same patient by more centers.
Criteria of IBD Diagnosis
The IBD diagnosis was based on clinical history, physical
examination, radiological studies, endoscopy, and histology,
as previously reported.22–25 All patients underwent upper and
lower (up to the terminal ileum) endoscopy with multiple
pinch biopsies and histologic assessment of mucosal speci-
mens.
CD was defined by evidence of a discontinuous chronic
inflammation of the gastrointestinal tract with or without
granulomas and supported by clinical, biochemical, and ra-
diological evidence.
UC was defined by the presence of continuous inflam-
mation limited to the colon with histologically typical chronic
inflammation limited to the mucosa.
IC was defined as inflammatory colitis with endoscopic
and histologic findings that were consistent with both CD and
UC. In addition, such patients did not present any evidence of
small bowel disease at the time of diagnosis.
Our study analyzed data from files entered up to De-
cember 31, 2003.
Statistical Analysis
A chi-square test was applied for category data; 1-way anal-
ysis of variance (ANOVA) was performed to compare mul-
tiple comparisons of continuous variables with Bonferroni
post-hoc test. Significance was set at P 0.05. SPSS v. 11.0
(Chicago, IL) was used for statistical analysis.
RESULTS
Population Characteristics
Up to the end of 2003 data from 1576 patients were entered
into the register. The majority (99%) were Caucasian, only 15
were immigrant children born abroad. Out of them, 810
patients (52%) had UC (365 males and 445 females, M:F
ratio 0.82), 635 (40%) had CD (344 males and 291 females,
M:F ratio 1.18), and 131 (8%) were registered as affected by
IC (77 males and 54 females, M:F ratio 1.42). The M:F ratio
of all patients with IBD was 0.99. The M:F ratio was lower
in UC patients, higher in those with IC, while its value was
intermediate in CD patients. This distribution was signifi-
cantly different from a random one.
Furthermore, we divided the patients into 3 groups
based on age of onset of symptoms: group 1 from 0–5 years,
group 2 from 6–12, and group 3 from 13–18. Sixty-four
percent of patients in the first group were diagnosed as
affected by UC, while patients diagnosed with IBD belonging
to the second and third groups were equally affected by UC
and CD, with a slight predominance of UC diagnoses in the
second group and a slight predominance of CD in the third
group (Table 1). IC was most prevalent in patients of the first
age group (14.5%) and declined with increasing age. The
highest number of cases of IBD was observed in the second
age group (n  905, 57%).
The mean interval from onset of symptoms to diagnosis
was higher in patients affected by CD and IC compared to
that observed in patients with UC, although this difference
was not statistically significant. We observed that the mean
interval from onset of symptoms to diagnosis decreased with
an increase of the patients’ age (Table 1).
Figure 1 reports the number of new diagnoses of UC,
CD, and IC/year. The total number of new diagnoses/year is
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in continuous increase. The total number of UC diagnoses is
greater than CD, even if in 2000 and 2003 the number of CD
were slightly higher than UC. There was an increase of the
overall incidence in the 3 diseases that rose from 0.89/105
inhabitants under 18 years of age in 1996 to 1.39/105 in 2003.
This increase was evident in each disease. From 1996 to 2003
the Italian population aged 18 years was about 10.5 million
and remained stable for the entire period.
Familial Incidence
Family history was reported in 1470 forms. Overall, a posi-
tive family history of IBD was found in 162 patients (11%)
(Table 4). Family history of UC was reported in 88% of
patients affected by UC, while 59% of relatives of patients
with CD were affected by the same disease; therefore, a high
concordance between the type of disease of the patients and
the type of disease of their relatives was observed.
Clinical Presentation
Tables 2–4 report the locations of the lesions at diagnosis in
the 3 types of disease. Almost half of the patients affected by
UC had a diffused form (pancolitis plus colitis extended to
the transverse colon), while only 7% of the patients had a
colitis limited to the rectum. The most frequent location in
patients affected by CD was the ileocolic one. Upper intes-
tinal tract involvement was present in 11% of CD patients.
The IC extensions were similar to those of UC.
No differences on the diseases extensions and locations
were observed in the 3 age groups (Tables 2–4). The most
frequent intestinal and extraintestinal manifestations at time
of diagnosis are reported in Table 5. The presence of blood in
the feces and abdominal pain were the most common features
in UC and IC patients, whereas abdominal pain and diarrhea,
not always with blood, were the most frequent symptoms in
CD patients. Perianal disease and fistulas were more common
in CD patients compared to UC and IC ones. Extraintestinal
manifestations at the time of diagnosis were more frequently
present in CD patients. In particular, loss of weight was
present in 50%, fever in 40%, anemia in 24%, asthenia in
18%, and joint involvement in 22% of CD patients.
Table 6 reports the associated diseases: hepatic involve-
ment was present in 5.2% of the patients and it was more
frequently observed in those affected by UC. Sclerosing
cholangitis was more frequent in UC patients (6%), whereas
in CD it was present in only 2 patients.
DISCUSSION
This study reports the clinical features of a large cohort of
pediatric Italian patients with IBD. As all Italian pediatric
gastroenterology centers participated in the study, we can
consider these data representative of the whole country.
In our study the number of UC diagnoses is higher than
CD (52% versus 40%) and these data are in contrast with the
ones reported in the Anglo-Saxon literature, but it agrees with
previous studies in the adult Italian population.26,27
We noticed a prevalence of females in UC, whereas
more males had CD. Our data agree with other studies that
also reported a significantly higher percentage of males com-
pared with females with CD.17 Conversely, this finding con-
FIGURE1. Newdiagnoses/year for the entire groupof patients,
divided for type of disease. [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]






Patients) UC vs CD UC vs IC CD vs IC
Mean age at onset (years) 9.2 ( 4.2) 10.6 ( 3.6) 8.2 (4.6) P  0.001 P  0.07 P  0.001
median 9.4 11.1 8.6
Mean age at diagnosis (years) 9.6 ( 4.1) 11.5 ( 3.5) 8.9 ( 4.6) P  0.001 P  0.3 P  0.001
median 9.9 11.7 9.2
Latency period between onset
of symptoms and diagnosis
(months) 5.8 ( 10.5) 10.1( 17) 9 (17.5) P  0.2 Ns Ns
Median 2 4 4
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trasts with previous studies, which have reported a slight
female preponderance in CD.12
We also observed that IBD was more frequent in pa-
tients aged 6–12 years (57%) and this is in accordance with
that reported by Turunen et al.21 It should be underlined that
20% of our population had onset of their symptoms under 6
years of age. Moreover, 28 patients (1.8% of total) had a
diagnosis of IBD before 1 year of age (11 affected by UC, 10
by CD, and 7 by IC).
IC diagnoses were more frequent in children aged 0–5
years (more than double that observed in older children).
Other authors report a higher incidence of IC diagnoses in
younger patients,21,22,28 and these data reflect the difficulties
in the primary diagnosis of IBD in very young children.
However, the IC incidence we observed is similar to that
indicated in other pediatric studies that report that IC ac-
counts for 10%–15% of newly diagnosed patients with
IBD.29,30
Our study shows a rising incidence of pediatric IBD in
Italy (1.39/105 inhabitants aged  18 years in 2003 versus
0.89 in 1996). The incidence increase was observed in all 3
diseases. The pediatric IBD incidence in Italy is remarkably
lower than the previous ones reported in other European
countries,16,18–21 as well as North America.17 In this study all
40 centers of pediatric gastroenterology in Italy, spread all
over the nation, participated and this guarantees that the data
collected are representative of the whole country and in-
cluded all pediatric patients with IBD. This is because IBD in
Italy is recognized as a social disease and pediatric patients
affected by IBD (the pediatric age in Italy is up to 18 years)
need to have their diagnosis certified by official pediatric
gastroenterology centers.
As reported in other surveys, the mean interval from
onset of symptoms and diagnosis is higher in patients affected
by CD and IC compared to that observed in patients with UC,
although this difference is not statistically significant. In
particular, it should be underlined that in children under 6
years of age the diagnosis of CD was made with an average
delay of 22 months, more than double compared to the other
2 age groups. Such delay can be explained by the objective
difficulties to diagnose CD and by the necessity of an accu-
rate differential diagnosis with other more frequent patholo-
gies in younger children.
Eleven percent of total patients had a positive family
history for IBD among first-degree relatives. Such data tally
with those reported by other authors,18 while it is much lower
than that reported by Heyman et al,22 who report a signifi-
cantly higher incidence in the group of patients under 2 years
of age affected by UC. Conversely, in our study we have not
noticed any significant difference regarding the IBD family
history in the 3 age groups among patients affected by UC,
while in CD its frequency results was much lower in younger
TABLE 2. UC: Locations at Diagnosis in the 3 Age Groups
Locations 0–5 Years 6–12 Years 13–18 Years Total
Pancolitis 85 (42%) 165 (37%) 65 (40%) 315 (39%)
Up to transverse colon 16 (25%) 49 (11%) 16 (10%) 81 (10%)
Up to left colon 39 (19%) 109 (24%) 39 (24%) 187 (23%)
Up to sigmoid colon 51 (25%) 88 (20%) 31 (19%) 170 (21%)
Rectum 12 (6%) 34 (8%) 11 (7%) 57 (7%)
Total 203 (100%) 445 (100%) 162 (100%) 810 (100%)
TABLE 3. CD: Locations at Diagnosis in the 3 Age Groups
0–5 Years 6–12 Years 13–18 Years Total
Ileocolon 28 (40%) 193 (48%) 90 (55%) 311 (49%)
Colon 24 (34%) 91 (23%) 37 (22%) 152 (24%)
Terminal ileum 9 (13%) 46 (12%) 9 (5%) 64 (10%)
Ileum 3 (4%) 29 (7%) 8 (5%) 40 (6%)
Ileum-colon-upper intestinal tract 4 (6%) 25 (6%) 10 (6%) 39 (6%)
Ileum-upper intestinal tract 1 (1.5%) 7 (1.75%) 6 (4%) 14 (2%)
Colon-upper intestinal tract 0 8 (2%) 4 (2.4%) 12 (2%)
Upper intestinal tract 1 (1.5%) 1 (0.25%) 1 (0.6%) 3 (1%)
Total 70 (100%) 400 (100%) 165 (100%) 635 (100%)
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patients. IC younger patients presented a higher frequency of
positive family history of IBD. Furthermore, as far as family
history is concerned, we observed a concordance of pathol-
ogy, higher for UC (88%) than for CD (59%).
Extended colitis (pancolitis and colitis extended up to
transverse colon) was the most frequent in both UC and IC,
as well as the ileocolic form of CD, thus confirming the
higher severity of such diseases in children.
Our data of extended colitis (49%) in our patients with
UC are more consistent with the data reported by Hyams et
al,3 who report pancolitis in 43% of a series of 171 patients
affected by UC. These data are much lower than that reported
by Kugathasan et al,17 who report an incidence of pancolitis
equal to 90% of their cases affected by UC at the time of
diagnosis. Ileocolic location was the most frequent one in our
CD patients, contrary to that reported by other authors who
indicated Crohn-colitis as the most frequent location in pe-
diatric patients.18
No differences were observed with what is reported in
the literature on intestinal and extraintestinal symptoms. Half
of our CD patients at the time of diagnosis presented with
weight loss, thus confirming that reported in other stud-
ies.31,32 Joint involvement was present with a frequency twice
that reported in the adult population affected by IBD.33,34
TABLE 4. IC: Location of Disease at Diagnosis
0–5 Years 6–12 Years 13–18 Years Total
Pancolitis 14 (31%) 23 (36%) 8 (37%) 45 (34%)
Up to transverse colon 3 (7%) 4 (6%) 4 (18%) 11 (9%)
Up to left colon 13 (29%) 18 (28%) 4 (18%) 35 (27%)
Up to sigmoid colon 15 (33%) 12 (19%) 2 (9%) 29 (22%)
Rectum 0 7 (11%) 4 (18%) 11 (9%)
Total 45 (100%) 64 (100%) 22 (100%) 131 (100%)
TABLE 5. IBD: Intestinal Symptoms
UC: 810 Patients CD: 635 Patients IC: 131 Patients
Intestinal
Bloody diarrhea 481 (59.5%) 170 (26.8%) 52 (39.4%)
Abdominal pain 403 (49.85%) 428 (67.4%) 61 (46.2%)
Rectal bleeding 378 (46.66%) 110 (17.32%) 65 (49.6%)
Chronic diarrhea 131 (16.2%) 238 (35.7%) 24 (18.2%)
Tenesmus 83 (10.3%) 18 (2.8%) 14 (10.6%)
Abdominal distention 22 (2.7%) 19 (3.0%) 6 (4.5%)
Vomiting 17 (2.1%) 56 (8.8%) 8 (6.1%)
Fecal occult blood 17 (2.1%) 29 (4.6%) 5 (3.8%)
Perianal disease 22 (2.7%) 94 (14.8%) 7 (5.3%)
Oral aphthous ulcers 17 (2.1%) 63 (9.9%) 3 (2.3%)
Constipation 10 (1.2%) 12 (1.9%) 1 (0.8)
Acute abdomen 2 (0.2%) 26 (4.1%) 21 (1.5%)
Fistulas 3 (0.4%) 41 (6.5%)
Subocclusion 2 (0.2%) 13 (2.0%) 1 (0.8%)
Extraintestinal
Weight loss 167 (20.6%) 318 (50.1%) 23 (17.4%)
Anemia 142 (17.6%) 151 (23.8%) 18 (13.6%)
Asthenia 51 (6.3%) 117 (18.4%) 14 (10.6%)
Joint pain 55 (6.8%) 143 (22.5%) 9 (6.9%)
Fever 102 (12.6%) 257 (40.5%) 17 (12.9%)
Anorexia 39 (4.8%) 125 (19.7%) 76 (5.3%)
Ocular disease 6 (0.7%) 11 (1.7%) 0
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Hepatic involvement was present in 5.25% of total IBD
patients and it was more frequent in UC. Sclerosing cholan-
gitis was more frequent in UC patients (6%). With regard to
the 5 patients registered as affected by both IC and sclerosing
cholangitis, most probably a further evaluation might reclas-
sify them as affected by UC.
In conclusion, our study indicates that also in Italy there
has been a progressive increase of IBD diagnoses in the
pediatric population. Diagnoses of UC are prevalent when
considering the series in toto, even if in the last years CD
diagnoses were slightly higher than UC. The IC incidence we
report (8%) is lower than that recently reported by other
studies.17,20,22 It should be pointed out that, compared to other
series, the Italian experience reports a high frequency of IBD
cases with an onset of symptoms in the first years of life (20%
of total cases) without differences in the locations at the
diagnosis in younger patients compared to older ones.
In summary, our study confirms the rising incidence of
IBD in Italy. The number of total diagnoses of UC is higher
than that of CD, in contrast with the data reported in the
literature. However, our data agree with that of the adult IBD
population reported by Italian gastroenterologists.
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